Lamina Therapeutics is a pioneering biotechnology company, developing innovative medical devices promoting patient's active live. Lamina’s technology consists of a three-dimensional biodegradable wound dressing with nano-reservoirs including active therapeutics in combination with patient’s own stem cells. This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions.
Lamina’s lead product lamina.ONE, offering a hybrid therapeutic action for the repair of cartilage as well as subchondral bone for a full recovery of the articular function, is expected to enter phase I/II clinical trials for isolated osteocartilaginous lesions in the knee by mid 2024.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 1, Rue Eugène Boeckel, Centre De Recherche En Biomédecine,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://lamina.eazyclick.be
- Keywords
- STRASBOURG.
- HQ
- Strasbourg, Grand Est
Lamina Therapeutics Questions
Lamina Therapeutics's website is https://lamina.eazyclick.be
Lamina Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/lamina-therapeutics
Lamina Therapeutics has
4 employees.
View email and phone details for 4
employees at Lamina Therapeutics.
Lamina Therapeutics's industry is
Biotechnology Research
Lamina Therapeutics's top competitors are
Blackleaf,
Kyron.bio,
Novalix,
Microomix,
Syndivia,
Satt Conectus,
Salto Therapeutics,
Ksilink,
Vaxinano,
Spectre.
Lamina Therapeutics's categories are Biotechnology Research
Lamina Therapeutics's founding year is 2020
